T1DM: abnormality in ovarian markers common in reproductive-age women

  • Clin Endocrinol (Oxf).

  • from Antara Ghosh
  • Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • In women with type 1 diabetes mellitus (T1DM) in their 30s, more than one-third had elevated anti-Müllerian hormone (AMH) consistent with presence of PCOS.
  • Abnormality in ovarian markers is common in this patient category and is not associated with irregular menses.
  • Elevated AMH could explain reduced fecundity in women with T1DM apart from irregular menses.

Why this matters

  • Women are at increased risk for infertility as they age, with risk more prominent in those with T1DM.
  • Very few studies have examined if ovarian markers influence infertility in this patient category.

Study design

  • Secondary analysis of 379 reproductive-age women (median age, 35 years) with T1DM.
  • Funding: NIH.

Key results

  • Irregular menses history was reported by 21% women, whereas 35% reported elevated AMH (≥26.70 pmol/L).
  • 12.2% and 2.7% women reported testosterone levels >1.74 and ≥3.05 nmol/L, respectively.
  • Younger age, lower insulin dosages (P=.0027) and higher testosterone concentrations were associated with higher AMH concentration.
  • No association was observed between AMH or testosterone concentrations and irregular menses.
  • Only age was associated with presence of at least 2 reproductive abnormalities with older age corresponding to lower odds (OR, 0.87; 95% CI, 0.80-0.94).

Limitations

  • Difficulty with fertility and actual thyroid hormone levels not assessed.